RXDX

Prometheus Biosciences, Inc. Common Stock

Delisted

RXDX was delisted on the 15th of June, 2023.

221 hedge funds and large institutions have $4.19B invested in Prometheus Biosciences, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 72 increasing their positions, 47 reducing their positions, and 16 closing their positions.

Holders
221
Holders Change
+77
Holders Change %
+53.47%
% of All Funds
3.57%
Holding in Top 10
17
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+70%
% of All Funds
0.27%
New
94
Increased
72
Reduced
47
Closed
16
Calls
$220M
Puts
$230M
Net Calls
-$10.2M
Net Calls Change
-$7.49M
Name Holding Trade Value Shares
Change
Shares
Change %
PI
226
Putnam Investments
Massachusetts
-$2.17M -36,713 Closed
Calamos Advisors
227
Calamos Advisors
Illinois
-$1.51M -25,612 Closed
JGC
228
J. Goldman & Co
New York
-$1.13M -19,190 Closed
RJFSA
229
Raymond James Financial Services Advisors
Florida
-$769K -13,036 Closed
CIP
230
Chartwell Investment Partners
Pennsylvania
-$555K -9,408 Closed
WG
231
Winton Group
United Kingdom
-$431K -7,311 Closed
VF
232
Virtu Financial
New York
-$292K -4,956 Closed
AIM
233
Aigen Investment Management
New York
-$248K -4,206 Closed
PI
234
PEAK6 Investments
Illinois
-$236K -4,000 Closed
Amundi
235
Amundi
France
-$206K -3,460 Closed
Walleye Capital
236
Walleye Capital
New York
-$96K -1,627 Closed